Parkinsonism & Related Disorders
Volume 16, Issue 5 , Pages 345-350 , June 2010

Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease

Received 11 October 2009 ,Revised 30 December 2009 ,Accepted 18 February 2010.

References 

  1. Bates G, Harper PS, Jones L. Huntington's disease. 3rd ed.. New York: Oxford University Press; 2002;
  2. Taylor N. Bramble D sleep disturbance and Huntingdon's disease. Br J Psychiatry. 1997;171:393
  3. Arnulf I, Nielsen J, Lohmann E, Schieffer J, Wild E, Jennum P, et al. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol. 2008;65:482–488
  4. Emser W, Brenner M, Stober T, Schimrigk K. Changes in nocturnal sleep in Huntington's and Parkinson's disease. J Neurol. 1988;235:177–179
  5. Videnovic A, Leurgans S, Fan W, Jaglin J, Shannon KM. Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Relat Disord. 2008;
  6. Wiegand M, Moller AA, Lauer CJ, Stolz S, Schreiber W, Dose M, et al. Nocturnal sleep in Huntington's disease. J Neurol. 1991;238:203–208
  7. Hurelbrink CB, Lewis SJ, Barker RA. The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's disease. J Neurol. 2005;252:642–647
  8. Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci. 2005;25:157–163
  9. Pallier PN, Maywood ES, Zheng Z, Chesham JE, Inyushkin AN, Dyball R, et al. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. J Neurosci. 2007;27:7869–7878
  10. Pallier PN, Morton AJ. Management of sleep/wake cycles improves cognitive function in a transgenic mouse model of Huntington's disease. Brain Res. 2009;1279:90–98
  11. Franzen PL, Buysse DJ. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci. 2008;10:473–481
  12. Brotini S, Gigli GL. Epidemiology and clinical features of sleep disorders in extrapyramidal disease. Sleep Med. 2004;5:169–179
  13. McCurry SM, Reynolds CF, Ancoli-Israel S, Teri L, Vitiello MV. Treatment of sleep disturbance in Alzheimer's disease. Sleep Med Rev. 2000;4:603–628
  14. Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM. Assessment of sleep and sleepiness in Parkinson disease. Sleep. 2003;26:1049–1054
  15. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–545
  16. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213
  17. Batschelet E. Circular statistics in biology. New York: Academic Press; 1981;
  18. Aziz NA, Pijl H, Frolich M, Schröder-van der Elst JP, Van der Bent C, Roelfsema F, et al. Delayed onset of the diurnal melatonin rise in patients with Huntington's disease. J Neurol. 2009;
  19. Aziz NA, Pijl H, Frolich M, van der Graaf AW, Roelfsema F, Roos RA. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease. J Clin Endocrinol Metab. 2009;94:1223–1228
  20. Buckley TM, Schatzberg AF. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab. 2005;90:3106–3114
  21. Aziz A, Fronczek R, Maat-Schieman M, Unmehopa U, Roelandse F, Overeem S, et al. Hypocretin and melanin-concentrating hormone in patients with Huntington disease. Brain Pathol. 2008;18:474–483
  22. Politis M, Pavese N, Tai YF, Tabrizi SJ, Barker RA, Piccini P. Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain. 2008;131:2860–2869
  23. Hansotia P, Wall R, Berendes J. Sleep disturbances and severity of Huntington's disease. Neurology. 1985;35:1672–1674
  24. Zisapel N. Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. CNS Drugs. 2001;15:311–328
  25. Riemersma-van der Lek RF, Swaab DF, Twisk J, Hol EM, Hoogendijk WJ, Van Someren EJ. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA. 2008;299:2642–2655
  26. Van Der Werf YD, Altena E, Schoonheim MM, Sanz-Arigita EJ, Vis JC, De Rijke W, et al. Sleep benefits subsequent hippocampal functioning. Nat Neurosci. 2009;12:122–123
  27. Silvestri R, Raffaele M, De Domenico P, Tisano A, Mento G, Casella C, et al. Sleep features in Tourette's syndrome, neuroacanthocytosis and Huntington's chorea. Neurophysiol Clin. 1995;25:66–77
  28. Ho AK, Gilbert AS, Mason SL, Goodman AO, Barker RA. Health-related quality of life in Huntington's disease: which factors matter most?. Mov Disord. 2008;24:572–576
  29. Buysse DJ, Reynolds CF, Kupfer DJ, Thorpy MJ, Bixler E, Manfredi R, et al. Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial. Sleep. 1994;17:630–637
  30. Jindal RD, Thase ME. Treatment of insomnia associated with clinical depression. Sleep Med Rev. 2004;8:19–30

☆ The review of this paper was entirely handled by an Associate Editor, Vincenzo Bonifati.

PII: S1353-8020(10)00047-7

doi: 10.1016/j.parkreldis.2010.02.009

Parkinsonism & Related Disorders
Volume 16, Issue 5 , Pages 345-350 , June 2010

Article Tools

* Image Usage & Resolution